Article, 2024

The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis

SCIENCE TRANSLATIONAL MEDICINE, ISSN 1946-6234, Volume 16, 739, 10.1126/scitranslmed.adk9109

Contributors

Skov, Martin [1] Ruijs, Titia Q. [2] [3] [4] [5] Gronnebaek, Thomas S. [1] Skals, Marianne [1] Riisager, Anders [1] Winther, Jeppe Blichfeldt [1] Dybdahl, Kamilla Lohde Tordrup [1] Findsen, Anders [1] Morgen, Jeanette J. [1] Huus, Nete [1] Broch-Lips, Martin [1] Nielsen, Ole B. [1] [6] de Cuba, Catherine M. K. E. [2] [3] [4] [5] Heuberger, Jules A. A. C. [2] de Kam, Marieke L. [2] Tannemaat, Martijn [3] [4] [5] Verschuuren, Jan J. G. M. [3] [4] [5] Knutsen, Lars J. S. [1] Kelly, Nicholas M. [1] Jensen, Klaus G. [1] Arnold, William D. [7] [8] Burghes, Arthur H. [9] [10] Olesen, Claus [1] [6] Bold, Jane [1] Petersen, Thomas K. [1] Quiroz, Jorge A. [1] Hutchison, John [1] Chin, Eva R. [1] Groeneveld, Geert J. [2] [3] [4] [5] Pedersen, Thomas H. (Corresponding author) [1] [6]

Affiliations

  1. [1] NMD Pharm AS, Palle Juul Jensens Blvd 82, DK-8200 Aarhus N, Denmark
  2. [NORA names: Other Companies; Private Research; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Ctr Human Drug Res, NL-2333 CL Leiden, Netherlands
  4. [NORA names: Netherlands; Europe, EU; OECD];
  5. [3] Leiden Univ, Med Ctr, Oncode Inst, NL-2333 ZA Leiden, Netherlands
  6. [NORA names: Netherlands; Europe, EU; OECD];
  7. [4] Leiden Univ, Med Ctr, Oncode Inst, NL-2333 ZA Leiden, Netherlands
  8. [NORA names: Netherlands; Europe, EU; OECD];
  9. [5] Leiden Univ, Med Ctr, Oncode Inst, NL-2333 ZA Leiden, Netherlands
  10. [NORA names: Netherlands; Europe, EU; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Data Provider: Clarivate